Cargando…
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
PURPOSE: The aim of this study was to develop and internally validate a medication nonadherence risk nomogram in a Chinese population of patients with inflammatory rheumatic diseases. PATIENTS AND METHODS: We developed a prediction model based on a training dataset of 244 IRD patients, and data were...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136915/ https://www.ncbi.nlm.nih.gov/pubmed/30237698 http://dx.doi.org/10.2147/PPA.S159293 |
_version_ | 1783355090668617728 |
---|---|
author | Wang, Huijing Zhang, Le Liu, Zhe Wang, Xiaodong Geng, Shikai Li, Jiaoyu Li, Ting Ye, Shuang |
author_facet | Wang, Huijing Zhang, Le Liu, Zhe Wang, Xiaodong Geng, Shikai Li, Jiaoyu Li, Ting Ye, Shuang |
author_sort | Wang, Huijing |
collection | PubMed |
description | PURPOSE: The aim of this study was to develop and internally validate a medication nonadherence risk nomogram in a Chinese population of patients with inflammatory rheumatic diseases. PATIENTS AND METHODS: We developed a prediction model based on a training dataset of 244 IRD patients, and data were collected from March 2016 to May 2016. Adherence was evaluated using 19-item Compliance Questionnaire Rheumatology. The least absolute shrinkage and selection operator regression model was used to optimize feature selection for the medication nonadherence risk model. Multivariable logistic regression analysis was applied to build a predicting model incorporating the feature selected in the least absolute shrinkage and selection operator regression model. Discrimination, calibration, and clinical usefulness of the predicting model were assessed using the C-index, calibration plot, and decision curve analysis. Internal validation was assessed using the bootstrapping validation. RESULTS: Predictors contained in the prediction nomogram included use of glucocorticoid (GC), use of nonsteroidal anti-inflammatory drugs, number of medicine-related questions, education level, and the distance to hospital. The model displayed good discrimination with a C-index of 0.857 (95% confidence interval: 0.807–0.907) and good calibration. High C-index value of 0.847 could still be reached in the interval validation. Decision curve analysis showed that the nonadherence nomogram was clinically useful when intervention was decided at the nonadherence possibility threshold of 14%. CONCLUSION: This novel nonadherence nomogram incorporating the use of GC, the use of nonsteroidal anti-inflammatory drugs, the number of medicine-related questions, education level, and distance to hospital could be conveniently used to facilitate the individual medication nonadherence risk prediction in IRD patients. |
format | Online Article Text |
id | pubmed-6136915 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61369152018-09-20 Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram Wang, Huijing Zhang, Le Liu, Zhe Wang, Xiaodong Geng, Shikai Li, Jiaoyu Li, Ting Ye, Shuang Patient Prefer Adherence Original Research PURPOSE: The aim of this study was to develop and internally validate a medication nonadherence risk nomogram in a Chinese population of patients with inflammatory rheumatic diseases. PATIENTS AND METHODS: We developed a prediction model based on a training dataset of 244 IRD patients, and data were collected from March 2016 to May 2016. Adherence was evaluated using 19-item Compliance Questionnaire Rheumatology. The least absolute shrinkage and selection operator regression model was used to optimize feature selection for the medication nonadherence risk model. Multivariable logistic regression analysis was applied to build a predicting model incorporating the feature selected in the least absolute shrinkage and selection operator regression model. Discrimination, calibration, and clinical usefulness of the predicting model were assessed using the C-index, calibration plot, and decision curve analysis. Internal validation was assessed using the bootstrapping validation. RESULTS: Predictors contained in the prediction nomogram included use of glucocorticoid (GC), use of nonsteroidal anti-inflammatory drugs, number of medicine-related questions, education level, and the distance to hospital. The model displayed good discrimination with a C-index of 0.857 (95% confidence interval: 0.807–0.907) and good calibration. High C-index value of 0.847 could still be reached in the interval validation. Decision curve analysis showed that the nonadherence nomogram was clinically useful when intervention was decided at the nonadherence possibility threshold of 14%. CONCLUSION: This novel nonadherence nomogram incorporating the use of GC, the use of nonsteroidal anti-inflammatory drugs, the number of medicine-related questions, education level, and distance to hospital could be conveniently used to facilitate the individual medication nonadherence risk prediction in IRD patients. Dove Medical Press 2018-09-10 /pmc/articles/PMC6136915/ /pubmed/30237698 http://dx.doi.org/10.2147/PPA.S159293 Text en © 2018 Wang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Wang, Huijing Zhang, Le Liu, Zhe Wang, Xiaodong Geng, Shikai Li, Jiaoyu Li, Ting Ye, Shuang Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram |
title | Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram |
title_full | Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram |
title_fullStr | Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram |
title_full_unstemmed | Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram |
title_short | Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram |
title_sort | predicting medication nonadherence risk in a chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136915/ https://www.ncbi.nlm.nih.gov/pubmed/30237698 http://dx.doi.org/10.2147/PPA.S159293 |
work_keys_str_mv | AT wanghuijing predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram AT zhangle predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram AT liuzhe predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram AT wangxiaodong predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram AT gengshikai predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram AT lijiaoyu predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram AT liting predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram AT yeshuang predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram |